Karl Stéfic

3.1k total citations · 1 hit paper
34 papers, 994 citations indexed

About

Karl Stéfic is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Karl Stéfic has authored 34 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 18 papers in Virology and 9 papers in Epidemiology. Recurrent topics in Karl Stéfic's work include HIV Research and Treatment (18 papers), HIV/AIDS Research and Interventions (14 papers) and HIV/AIDS drug development and treatment (12 papers). Karl Stéfic is often cited by papers focused on HIV Research and Treatment (18 papers), HIV/AIDS Research and Interventions (14 papers) and HIV/AIDS drug development and treatment (12 papers). Karl Stéfic collaborates with scholars based in France, United States and Australia. Karl Stéfic's co-authors include Catherine Gaudy‐Graffin, Louis Bernard, Leslie Grammatico‐Guillon, Émeline Laurent, Adrien Lemaignen, F. Bruyère, Céline Bourbao-Tournois, Thomas Flament, Nicole Ferreira-Maldent and Claudia Carvalho-Schneider and has published in prestigious journals such as Nature Communications, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Karl Stéfic

30 papers receiving 964 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Follow-up of adults with noncritical COVID-19 two months after symptom onset

2020 513 citations Claudia Carvalho-Schneider, Émeline Laurent et al. Clinical Microbiology and Infection profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karl Stéfic France	12	619	494	252	141	102	34	994
Caitlin R. Wolf United States	11	917 1.5×	526 1.1×	250 1.0×	178 1.3×	94 0.9×	23	1.4k
Gillian S. Tomlinson United Kingdom	13	466 0.8×	505 1.0×	241 1.0×	109 0.8×	245 2.4×	22	1.1k
Nollaig M. Bourke Ireland	17	299 0.5×	329 0.7×	130 0.5×	154 1.1×	166 1.6×	36	977
Catherine Gaudy‐Graffin France	13	513 0.8×	458 0.9×	249 1.0×	89 0.6×	321 3.1×	39	1.1k
Francesca Bai Italy	17	319 0.5×	306 0.6×	223 0.9×	86 0.6×	180 1.8×	43	926
Lars‐Magnus Andersson Sweden	9	279 0.5×	360 0.7×	103 0.4×	63 0.4×	143 1.4×	19	712
Valérie Pourcher France	17	524 0.8×	280 0.6×	65 0.3×	88 0.6×	231 2.3×	71	1.0k
Monique H. Reijers Netherlands	14	666 1.1×	330 0.7×	144 0.6×	32 0.2×	178 1.7×	33	1.1k
Steffen Leth Denmark	12	461 0.7×	208 0.4×	77 0.3×	149 1.1×	153 1.5×	41	950
Jeremy Nel South Africa	13	416 0.7×	209 0.4×	119 0.5×	43 0.3×	207 2.0×	43	682

Countries citing papers authored by Karl Stéfic

Since Specialization

Citations

This map shows the geographic impact of Karl Stéfic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Stéfic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Stéfic more than expected).

Fields of papers citing papers by Karl Stéfic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Stéfic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Stéfic. The network helps show where Karl Stéfic may publish in the future.

Co-authorship network of co-authors of Karl Stéfic

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Stéfic. A scholar is included among the top collaborators of Karl Stéfic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Stéfic. Karl Stéfic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wirden, Marc, Marie‐Laure Chaix, Stéphanie Marque‐Juillet, et al.. (2025). Benefits of HIV‐1 transmission cluster surveillance: a French retrospective observational study of the molecular and epidemiological co‐evolution of recent circulating recombinant forms 94 and 132. Journal of the International AIDS Society. 28(2). e26416–e26416. 1 indexed citations

Zafilaza, Karen, Vincent Foulongne, Maud Salmona, et al.. (2024). Comparison of Dual Monoclonal Antibody Therapies for COVID-19 Evolution: A Multicentric Retrospective Study. Viruses. 16(10). 1542–1542.

Chaix, Marie‐Laure, Karl Stéfic, Caroline Lascoux‐Combe, et al.. (2024). Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in French primary HIV‐1 infected patients in 2020–2023. Journal of Medical Virology. 96(10). e29948–e29948. 3 indexed citations

Gras, Guillaume, et al.. (2024). Factors Associated with PrEP Persistence and Loss of Follow-Up: A 5-Year Historic Cohort. Archives of Sexual Behavior. 53(7). 2445–2452. 4 indexed citations

André‐Garnier, Elisabeth, Laurence Bocket, Thomas Bourlet, et al.. (2024). Use of genotypic HIV DNA testing: a DELPHI-type consensus. Journal of Antimicrobial Chemotherapy. 79(3). 578–588. 3 indexed citations

Meur, Nolwenn Le, et al.. (2023). Performance of French medico-administrative databases in epidemiology of infectious diseases: a scoping review. Frontiers in Public Health. 11. 1161550–1161550. 3 indexed citations

Eymieux, Sébastien, Christophe Gaborit, Hélène Blasco, et al.. (2022). ELISA-Based Analysis Reveals an Anti-SARS-CoV-2 Protein Immune Response Profile Associated with Disease Severity. Journal of Clinical Medicine. 11(2). 405–405. 2 indexed citations

Dufloo, Jérémy, Cyril Planchais, Stéphane Frémont, et al.. (2022). Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells. Nature Communications. 13(1). 630–630. 21 indexed citations

Wang, Chuangqi, Timothy E. Schlub, Wen‐Han Yu, et al.. (2022). Landscape of Human Immunodeficiency Virus Neutralization Susceptibilities Across Tissue Reservoirs. Clinical Infectious Diseases. 75(8). 1342–1350. 7 indexed citations

10.

Marlet, Julien, Philippe Gatault, Hélène Longuet, et al.. (2021). Antibody Responses after a Third Dose of COVID-19 Vaccine in Kidney Transplant Recipients and Patients Treated for Chronic Lymphocytic Leukemia. Vaccines. 9(10). 1055–1055. 29 indexed citations

11.

Blanchardière, Arnaud de La, Julia Dina, Karl Stéfic, et al.. (2021). Case Report: Leishmania and HIV Co-Diagnosis: How to Understand Medical History?. Frontiers in Immunology. 12. 669723–669723. 5 indexed citations

12.

Bal, Antonin, Grégory Destras, Alexandre Gaymard, et al.. (2021). Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020. Eurosurveillance. 26(3). 130 indexed citations

13.

Marlet, Julien, Antoine Guillon, S. Marchand‐Adam, et al.. (2020). Clinical performance of four immunoassays for antibodies to SARS-CoV-2, including a prospective analysis for the diagnosis of COVID-19 in a real-life routine care setting. Journal of Clinical Virology. 132. 104633–104633. 10 indexed citations

14.

Blasco, Hélène, Laurent Plantier, Antoine Lefèvre, et al.. (2020). The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism. Scientific Reports. 10(1). 16824–16824. 92 indexed citations

15.

Salmona, Maud, Karl Stéfic, Nadia Mahjoub, et al.. (2020). Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring. Virology Journal. 17(1). 20–20. 3 indexed citations

16.

Carvalho-Schneider, Claudia, Émeline Laurent, Adrien Lemaignen, et al.. (2020). Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clinical Microbiology and Infection. 27(2). 258–263. 513 indexed citations breakdown →

17.

Stéfic, Karl, et al.. (2019). Impact of HIV-1 Diversity on Its Sensitivity to Neutralization. Vaccines. 7(3). 74–74. 13 indexed citations

18.

Stéfic, Karl & Françis Barin. (2019). Central nervous system compartmentalization of HIV, an interesting model of viral evolution: from theory to clinical implications. Virologie. 23(6). 359–371.

19.

Barin, Françis & Karl Stéfic. (2018). Anticorps neutralisants tri-spécifiques. médecine/sciences. 34(2). 109–111.

20.

Stéfic, Karl, Antoine Chaillon, Alain Moreau, et al.. (2017). Probing the compartmentalization of HIV-1 in the central nervous system through its neutralization properties. PLoS ONE. 12(8). e0181680–e0181680. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact